Günenç D - Search Results

1

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.

Yıldırım HÇ, Mutlu E, Chalabiyev E, Özen M, Keskinkılıç M, Ön S, Çelebi A, Dursun B, Acar Ö, Kahraman S, Aykan MB, Kaman Ö, Doğan A, Erdoğan AP, Melisa Celayir Ö, Günenç D, Güven DC, Vedat Bayoğlu İ, Yavuzşen T, Hacıbekiroğlu İ, İnanç M, Kılıçkap S, Yalçın Ş, Aksoy S. Yıldırım HÇ, et al. Among authors: gunenc d. Breast. 2022 Dec;66:85-88. doi: 10.1016/j.breast.2022.09.009. Epub 2022 Sep 30. Breast. 2022. PMID: 36208540 Free PMC article.

2

Immunotherapy-induced granulomatous reaction in patients with melanoma.

Taskaynatan H, Gunenc D, Ön S, Mizrak A, Samancilar O, Karaca B. Taskaynatan H, et al. Among authors: gunenc d. Melanoma Res. 2022 Aug 1;32(4):286-290. doi: 10.1097/CMR.0000000000000815. Epub 2022 Jun 22. Melanoma Res. 2022. PMID: 35752875

3

PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment.

Gursoy P, Çakar B, Gunenc D, Nart D, Çınkooğlu A, Katgı N. Gursoy P, et al. Among authors: gunenc d. Turk Thorac J. 2022 Jan;23(1):45-51. doi: 10.5152/TurkThoracJ.2021.21151. Turk Thorac J. 2022. PMID: 35110200 Free PMC article.

4

Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model.

Taskin B, Erdoğan MA, Yiğittürk G, Günenç D, Erbaş O. Taskin B, et al. Among authors: gunenc d. Gastroenterol Res Pract. 2017;2017:7942531. doi: 10.1155/2017/7942531. Epub 2017 Aug 17. Gastroenterol Res Pract. 2017. PMID: 28912805 Free PMC article.

5

Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN).

Gunenc D, Issa W, Gerald T, Zhou Q, Zhang S, Ibezue IC, Bhanvadia R, Tachibana I, Brugarolas J, Hammers H, Qin Q, Kapur P, Woldu S, Gaston K, Lotan Y, Cadeddu J, Wang AZ, Margulis V, Zhang T. Gunenc D, et al. Clin Genitourin Cancer. 2024 Oct;22(5):102177. doi: 10.1016/j.clgc.2024.102177. Epub 2024 Jul 23. Clin Genitourin Cancer. 2024. PMID: 39218752

6

Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature.

Ozluk AA, Gunenc D, Yildirim SS, Karaca B. Ozluk AA, et al. Among authors: gunenc d. Melanoma Res. 2024 Aug 1;34(4):335-342. doi: 10.1097/CMR.0000000000000969. Epub 2024 Apr 29. Melanoma Res. 2024. PMID: 38691011 Review.

7

Successful application of chemosaturation with percutaneous hepatic perfusion in metastatic uveal melanoma patient progressing after systemic treatment options: a case report.

Gunenc D, Ozluk AA, Yıldırım UM, Ascierto PA, Karaca B. Gunenc D, et al. Front Oncol. 2024 Apr 10;14:1355971. doi: 10.3389/fonc.2024.1355971. eCollection 2024. Front Oncol. 2024. PMID: 38660135 Free PMC article.

8

Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs.

Zhang T, Forde PM, Sullivan RJ, Sharon E, Barksdale E, Selig W, Ebbinghaus S, Fusaro G, Gunenc D, Battle D, Burns R, Hurlbert MS, Stewart M, Atkins MB. Zhang T, et al. Among authors: gunenc d. J Immunother Cancer. 2023 May;11(5):e006555. doi: 10.1136/jitc-2022-006555. J Immunother Cancer. 2023. PMID: 37137552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters